Augmedix (Nasdaq: AUGX), a leader in ambient AI medical
documentation and data solutions, today announced new positive data
and product enhancements for Augmedix Go, its ambient AI medical
documentation product.
Now supporting over 50 medical specialties, the Augmedix Go
mobile app optimizes ambient AI technology to produce comprehensive
draft medical notes in real time by processing the natural
conversations between clinicians and patients.
New data from survey responses from more than a dozen enterprise
and independent healthcare organizations found that clinicians in
ambulatory care settings save up to one hour or more per clinic day
by using Augmedix Go. Additionally, 94% of clinicians surveyed
reported that Augmedix Go helps them better focus on their
patients.
“Hospitals and health systems have a growing need for a fully
automated solution that can deliver the high quality notes at scale
that our suite of medical documentation products offer; we launched
Augmedix Go in response to this market demand,” said Manny
Krakaris, CEO of Augmedix. “The promising data and enthusiastic
feedback we’re hearing from our customers reinforces our commitment
to delivering ambient AI solutions that combat administrative
burden and clinician burnout.”
Augmedix Go utilizes a collection of large language models
(LLMs) for different note sections, including Google Cloud’s
MedLM’s suite of medically-tuned models. This collection of LLMs is
used in conjunction with Augmedix’s proprietary natural language
processing (NLP) and structured data sets, bringing the most
powerful generative AI capabilities to the healthcare industry. By
utilizing multiple models that cross-check each other, Augmedix is
delivering high quality notes that instill trust among
clinicians.
“The Augmedix Go note reads like a clinician wrote it,” said
Mary Kate Case, PA-C, heart and vascular care. “Other AI products I
have used sound like a machine produced the note.”
Augmedix Go seamlessly integrates with leading EHRs, including
Epic, Oracle Cerner, Meditech, and athenahealth, allowing for
proper organization of previously unstructured documentation into
appropriate clinical data domains. Go uses a problem-based note
approach, with note content organized within the History of Present
Illness (HPI) and Assessment and Plan (A&P) sections of the
patient’s chart. This approach provides an effortless, intuitive
note structure for easy review, unlike medical documentation
products that lump note content from multiple problems into a
single paragraph.
Leveraging experience from producing 10 million high-quality
notes over 11 years, Augmedix has developed specialty-specific
models that produce detailed medical notes for more than 50 acute
care and ambulatory specialties. Augmedix Go uses proprietary
quality scoring rubrics to train models that reflect the
specialty-specific visit types, complaints, medical terminology,
note sections, and organization. A feedback loop exists between the
AI-generated content and human subject matter experts across all
specialties to continuously improve note quality.
As an example, to help oncologists better focus
on their patients, Augmedix Go automatically generates the HPI with
oncologic history, the interval history with information from the
last visit, a comprehensive physical exam including the ECOG
(Eastern Cooperative Oncology Group) score, and an A&P that
incorporates an impression detailing the status of disease and
treatment plans.
Clinicians use Augmedix Go to support their individual workflows
with features such as additional recordings for multiple
interactions across a single patient visit. Behind the scenes, the
platform stitches together the recordings to create a comprehensive
and structured problem-based or visit-based note, depending on the
specialty and organizational preferences. Over half of clinicians
use this new feature.
About AugmedixAugmedix (Nasdaq: AUGX) empowers
clinicians to connect with patients by liberating them from
administrative burden through the power of ambient AI, data, and
trust.
The platform transforms natural conversations into organized
medical notes, structured data, and point-of-care notifications
that enhance efficiency and clinical decision support.
Incorporating data from millions of interactions across all care
settings, Augmedix collaborates with hospitals and health systems
to improve clinical, operational, and financial outcomes.
Augmedix is headquartered in San Francisco, CA, with offices
around the world. To learn more, visit www.augmedix.com.
Forward-Looking Statements
This press release contains “forward-looking statements” that
involve a number of risks and uncertainties. Words such as
“believes,” “may,” “will,” “estimates,” “potential,” “continues,”
“anticipates,” “intends,” “expects,” “could,” “would,” “projects,”
“plans,” “targets,” “excited,” “optimistic,” and variations of such
words and similar expressions are intended to identify
forward-looking statements. Such forward-looking statements
include, without limitation, statements regarding the time savings
clinicians will experience with Augmedix Go; statements related to
Augmedix Go allowing clinicians to save time and focus more on the
patient; statements related to hospitals and health systems growing
need for a fully automated solutions; statements regarding the
level of satisfaction clinicians will experience with Augmedix Go;
statements regarding Augmedix bringing the most powerful generative
AI capabilities to the healthcare industry; and statements
regarding Augmedix Go’s effortless, intuitive note organization.
Actual results could differ materially from those stated or implied
in forward-looking statements due to a number of factors, including
but not limited to, risks detailed in our most recent Form 10-K
filed with the U.S. Securities and Exchange Commission on April 17,
2023, as well as other documents that may be filed by us from time
to time with the U.S. Securities and Exchange Commission. The
forward-looking statements included in this press release represent
our views as of the date of this press release. We undertake no
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise. These forward-looking statements should not be relied
upon as representing our views as of any date subsequent to the
date of this press release.
Contact Information
Investors:Matt Chesler, CFAFNK
IR646-809-2183augx@fnkir.cominvestors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From May 2024 to Jun 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Jun 2023 to Jun 2024